1,441
Views
86
CrossRef citations to date
0
Altmetric
Original Article

Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases

&
Pages 423-437 | Accepted 25 Nov 2009, Published online: 11 Dec 2009

References

  • Arbes SJ Jr, Gergen PJ, Elliott L, et al. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377-83
  • Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43
  • Høst A, Koletzko B, Dreborg S, et al. Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child 1999;81:80-4
  • Greer FR, Sicherer SH, Burks AW. American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008;121:183-91
  • Høst A, Halken S, Muraro A, et al. Dietary prevention of allergic diseases in infants and small children. Pediatr Allergy Immunol 2008;19:1-4
  • Baumgartner M, Brown CA, Exl B-M, et al. Controlled trials investigating the use of partially hydrolyzed whey formula for dietary prevention of atopic manifestations until 60 months of age: an overview using meta-analytical techniques. Nutr Res 1998;18:1425-42
  • Hays T, Wood RA. A systematic review of the role of hydrolyzed infant formulas in allergy prevention. Arch Pediatr Adolesc Med 2005;159:810-16
  • Osborn DA, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev 2006 Oct 18;(4):CD003664. Review. PubMed PMID: 17054180
  • Fewtrell MS, Kennedy K, Singhal A, et al. How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?. Arch Dis Child 2008;93:458-61
  • Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd
  • Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds.) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. [updated September 2008]. Cochrane Collaboration, 2008. Available at: www.cochrane-handbook.org [Last accessed 30 September 2009]
  • Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-34
  • Chan YH, Shek LPC, Aw M, et al. Use of hypoallergenic formula in the prevention of atopic disease among Asian children. J Paediatr Child Health 2002;38:84-8
  • De Seta L, Siani P, Cirillo G, et al. Prevention of allergic disease by an hypoallergenic formula: preliminary results at the 24 months follow-up. Medical and Surgical Pediatrics 1994;16:251-4
  • Halken S, Hansen KS, Jacobsen HP et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr Allergy Immunol 2000;11:149-61
  • Lam BCC, Yeung CY. The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Unpublished, 1992
  • Marini A, Agosti M, Motta G, et al. Effects of a dietary and environmental prevention program on incidence of allergic symptoms in high atopic risk infants: three years follow-up. Acta Paediatr 1996;85(Suppl. 414):1-21
  • Nentwich I, Michkova E, Nevoral J, et al. Cow’s milk-specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy 2001;56:1144-56
  • Porch MC, Shahane A, Leiva L, et al. Influence of breast milk, soy or two hydrolyzed formulas on the development of allergic manifestations in infants at risk. Nutr Res 1998;18:1413-24
  • Tsai YT, Chou CC, Hsieh KH. The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1991;32:137-44
  • Vandenplas Y, Deneyer M, Sacre L, et al. Preliminary data on a field study with a new hypo-allergic formula. Eur J Pediatr 1988;148:274-7
  • Vandenplas Y, Hauser B, Van den Borre C, et al. Effect of a whey hydrolysate prophylaxis of atopic disease. Ann Allergy 1992;68:419-24
  • Vandenplas Y, Hauser B, Van den Borre C, et al. The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. Eur J Pediatr 1995;154:488-94
  • von Berg A, Koletzko S, Grübl A et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow’s milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 2003;111:533-40
  • von Berg A, Koletzko S, Filipiak-Pittroff B, et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol 2007;119:718-25
  • von Berg A, Filipiak-Pittroff B, Krämer U, et al. GINI plus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008;121:1442-7
  • Willems R, Duchateau J, Magrez P, et al. Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Ann Allergy 1993;71:147-50
  • Chandra RK, Singh G, Shridhara B. Effect of feeding whey hydrolysate, soy and conventional cow milk formulas on incidence of atopic disease in high risk infants. Ann Allergy 1989;63:102-6
  • Chandra RK, Hamed A. Cumulative incidence of atopic disorders in high risk infants fed whey hydrolysate, soy, and conventional cow milk formulas. Ann Allergy 1991;67(2 Pt 1):129-32
  • Chandra RK, Hamed A, Prasad C, et al. Cumulative incidence of allergic disorders in high-risk infants fed whey hydrolysate, soy, and conventional cow’s milk formulas. Am J Clin Nutr 1992;56:758
  • Chandra RK. Five-year follow-up of high-risk infants with family history of allergy who were exclusively breast-fed or fed partial whey hydrolysate, soy, and conventional cow’s milk formulas. J Pediatr Gastroenterol Nutr 1997;24:380-8
  • White C. Three journals raise doubts on validity of Canadian studies. Br Med J 2004;328:67
  • Deeks JJ, Higgins JPT, Altman DG. Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (eds.) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. [updated September 2008]. Cochrane Collaboration, 2008. Available at: www.cochrane-handbook.org [Last accessed 30 September 2009]
  • Brand PL, Vlieg-Boerstra BJ, Dubois AE. Dietary prevention of allergic disease in children: are current recommendations really based on good evidence?. Pediatr Allergy Immunol 2007;18:475-9
  • Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available at: www.cochrane-handbook.org [Last accessed 30 September 2009]
  • Exl BM, Deland U, Wall M, et al. Zug–Frauenfeld nutritional survey (‘Zuff study’): allergen-reduced nutrition in a normal infant population and its health-related effects: results at the age of six months. Nutrition Res 1998;18:1443-62
  • Exl BM, Deland U, Secretin MC, et al. Improved general health status in an unselected infant population following an allergen reduced dietary intervention programme. The ZUFF-study-programme. Part I: Study design and 6-month nutritional behaviour. Eur J Nutr 2000;39:89-102
  • Exl BM, Deland U, Secretin MC, et al. Improved general health status in an unselected infant population following an allergen-reduced dietary intervention programme: the ZUFF-study-programme. Part II: infant growth and health status to age 6 months. ZUg–FrauenFeld. Eur J Nutr 2000;39:145-56
  • Iikura Y, Akimoto K, Ebisawa M, et al. Effect of hydrolyzed whey protein formula for babies on development of allergic symptoms during infancy. In: AL de Weck & HA Sampson (eds.) Nestlé Nutrition Workshop Series ‘Intestinal Immunology and Food Allergy’. New York: Nestec Ltd, Vevey/Raven Press Ltd, 1995;34:231–48
  • Barberi I, Salpietro DC, Catalioto G, et al. Clinical trial of a new hypoallergenic formula in risk infants. 2nd World Congress of Perinatal Medicine, Rome and Florence, 19–24 September 1993
  • D’Agata A, Betta P, Sciacca P, et al. Role of dietary prevention in newborns at risk for atopy. Results of a follow-up study [Italian]. Pediatr Med Chir 1996;18:469-72
  • Bardare M, Vaccari A, Allievi E, et al. Influence of dietary manipulation on incidence of atopic disease in infants at risk. Ann Allergy 1993;71:366-71
  • Laforgia N, Capolupo I, Grassi A, et al. Atopic manifestations, growth and nutritional data in newborns at high risk for allergy fed serum protein hydrolysate: 2-year follow-up [Italian]. Pediatr Med Chir 1996;18:477-80
  • Marini A, Agosti M, Motta G. A dietary prevention program including whey hydrolyzed formula for high risk atopic babies: 0–24 months follow-up. Dev Physiopathol Clin 1990;1:131-41
  • Schmidt E, Eden-Kohler J, Tonkaboni F, et al. Alimentary allergy prevention in infants with increased allergic risk: the effect of different feeding regimens in the first 6 months on atopic manifestations during the first year of life. A large scale feeding trial. Nestle Nutritional Workshop: Intestinal Immunology and Food Allergy Vol. 34, Raven Press, 1995:231-48

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.